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Introduction 
Miniaturization of coordination polymers (CPs)[1] to the nanoscale 
represents a novel class of highly customizable functional 
particles for drug-delivery on combining the rich diversity, 
chemistry and properties of coordination complexes to the 
advantages of nanomaterials.[2] Metal-organic frameworks 
(MOFs) have already been successfully used with this aim; MOFs 
allow control over the release cargo via modification of tunable 
pores with an exceptionally high surface area and therefore 
loading capacity. The crystalline nature of MOFs facilitates 
analyses of host–guest interactions and systematic drug 
encapsulation and release studies, as well as theoretical 
models.[3] In addition to MOFs, amorphous nanoscale 
coordination polymer particles (CPPs) have recently emerged as 
an effective alternative for the use of coordination polymer as 
drug delivery carriers. Since first being reported less than a 
decade ago,[4]  nanoscale CPPs have already shown their 
efficacy as encapsulation carriers,[5] sensors,[6] biopolymers,[7] 
drug delivery,[8] or theranostics[9] platforms. Nonetheless, the 
synthetic methodology for CPPs is in its fledgling stage. To date, 
there have not been any reports of methods to systematically 
control the surface functionality of CPPs or to master their 
modification at the nanoscale. This lack of methodology is 
perhaps one of the greatest roadblocks to the advancement of 
CPPs into high added-value medical applications. This is 
especially relevant for drug delivery applications, where 
significant advances involve the development of nanoparticles 
with specific surface functions and/or recognition chemicals that 
allow for an enhanced biological activity, imaging or stability. 
Although functionalization of metal or metal oxide,[10,11] MOFs [12] 
or pure organic polymer nanoparticles [13] can be achieved with a 
high degree of precision, this new family of metal-organic 
coordination polymer particles remained unexplored. 
The most direct approach to achieve this goal is a priori the 
hierarchical assembly of nanoparticles using ligands with the 
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Abstract: Functionalization of nanoparticles can 
significantly influence their properties and potential 
applications. Although researchers can now functionalize 
metal, metal oxide or organic polymer nanoparticles with a 
high degree of precision, controlled surface functionalization 
of nanoscale coordination polymer particles (CPPs) has 
remained a significant research challenge. This lack of 
methodology is perhaps one of the greatest roadblocks to 
the advancement of CPPs into high added-value drug 
delivery applications. Here we report having achieved this 
goal through stepwise formation and functionalization 
protocol. We fabricated robust nanoparticles with enhanced 
thermal and colloidal stabilities  by incorporation of carboxyl 
group and the surface carboxyl groups can be subsequently 
functionalized through well-known peptide coupling 
reactions. The set of chemistries that we employed as 
proof-of-concept enabled a plethora of new functional 
improvements for the application of CPPs as drug delivery 
carriers, including enhanced colloidal stabilities and the 
incorporation of additional functional groups such as PEG or 
fluorescent dyes that enabled tracking of their cellular 
uptake. Finally, we ascertained the cytotoxicity of the new 
CPP nanoparticles loaded with camptothecin to human 
breast adenocarcinoma (MCF-7). Efflux measurements 
show that the encapsulation of camptothecin enhances the 
potency of the drug in 6.5-fold and increases the drug 
retention within the cell. 
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desired functional group, a small fraction of which is expected to 
remain on the nanoparticle surface. However, this approach is 
limited by the unpredictable interplay of supramolecular 
interactions between ligands according to its chemical 
composition, steric constraints and bulk material properties, all of 
which can influence the final composition, stability and 
morphology of the nanoparticles. Thus, we envisioned the use of 
ligands bearing a reactive group that enables reproducible 
fabrication of nanoscale platforms and their post-synthetic 
modification. With this aim, herein we report the fabrication of 
CPPs incorporating ligands containing carboxyl groups (Figure 1 
top), which have been shown to reinforce both the chemical and 
colloidal stability of the nanoparticles. Moreover, the surface 
carboxylates can be transformed into myriad functionalities 
through well-known condensation reactions, as schematically 
shown in Figure 1 down. The plethora of functionalities added 
range from polyethyleneglycol (PEG) to the incorporation of 
fluorescent dyes enabling tracking of their cellular uptake. Finally, 
we ascertained the successful cytotoxicity of the new CPP 
nanoparticles loaded with camptothecin to human breast 
adenocarcinoma cells (MCF-7). Efflux measurements showed a 
6.5 fold increase in antitumoral activity of the encapsulate drug in 
comparison with free drug. This represents a notable evidence of 
the potential utility of these CPPs as chemotherapeutic 
nanomedicines with high uptake and in vitro activity under low 
dosing regimen.  
Figure 1. (Top) Schematic of the formation of polymeric chains and 
confinement into a nanostructure by fast precipitation. (Bottom) Schematic of 
the functionalization of nanoparticles containing carboxyl groups on the surface 
with different species containing amino groups mediated by carbodiimine 
coupling reaction. 
 
Results and Discussion 
In a typical experiment, an aqueous solution of 
M(CH3COO)2•xH2O (where M stands for cobalt or iron) was 
added to an ethanolic solution combining two co-ligands: 3,4-
dihydroxycinnamic acid (dhc), used to introduce the carboxylic 
acid group on the structure, and 1,4-bis(imidazol-1-
ylmethyl)benzene (bix), used as a counter ligand to induce 
polymerization. After vigorous stirring at room temperature a pale 
brown greenish precipitate was obtained for the cobalt complex 
(CPP0-Co) and a dark brown one for the iron sample (CPP0-Fe). 
The precipitate was then collected by centrifugation, washed 
several times with ethanol and dried under vacuum. SEM and 
TEM images revealed spherical nanoparticles with an average 
diameter of 110±17nm (CPP0-Co) or 94±11 nm (CPP0-Fe) (see 
Figure 2), as confirmed by dynamic light scattering (DLS). We 
were also able to control the average size by simply regulating 
the stirring rate (see Supporting Information S1). The reaction 
conditions were adjusted to assure a particle mean size close to 
100 nm, an optimal range to be applied as drug delivery 
systems.[14] The chemical analysis data agreed with the general 
chemical formula [M(dhc)2(bix)]n.  X-ray Powder Diffraction data 
showed the typical pattern for an amorphous material. Fourier-
transform infrared (FT-IR) spectra evidenced the coordination of 
the bix and catechol ligands to the metal and the permanence of 
the acidic group. Energy-Dispersive X-ray Spectroscopy 
confirmed the presence of the metal (Co or Fe) and of carbon, 
oxygen and nitrogen (see Supporting Information S2).  
Figure 2. SEM images of a) CPP0-Co and b) CPP0-Fe nanoparticles showing 
good homogeneity and narrow size distribution; c) Solid samples and (d) water 
dispersions of CPP0-Co (pale brown) and CPP0-Fe (dark brown); e) Zeta-
potential values for CPP0-Co (green dots) and CPP0-Fe (blue dots) at different 
pHs; f) DLS size dispersion measurements for CPP0-Co (green) and CPP0-Fe 
(blue) at different pHs. 
 
   Chemical and colloidal stability. Surface carboxylic 
groups already enable control on the colloidal dispersion in water 
mainly by electrostatic repulsions, as already shown for different 
families of inorganic nanoparticles.[15] Zeta-potential 
measurements on CPP0-Co and CPP0-Fe in aqueous buffer 
(~20 mM) at neutral pH (pH 7.3) gave values of –25.0 ± 8.2 mV 
and –34.3 ± 9.7 mV, respectively. The resulting colloidal 
suspensions are stable for a few days. From here, the surface 
charge can be tuned by simply adjusting the pH of the buffer (see 
Figure 2e-f)—a feature which has been harnessed in other 
families of nanoparticles to modulate properties such as colloidal 
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stability, toxicity and biocompatibility.[16] For instance, a pH 
increase to 9.0 led to a more negative zeta-potential value of -
57.7 ± 6.2 mV (CPP0-Co) and -61.2± 5.1 mV (CPP0-Fe) and 
consequently, to less particle aggregation and therefore, more 
stable dispersions during several weeks due to an increase in 
Coulombic repulsions (increasing the pH further, to ~12.0, 
resulted in chemical decomposition as evidenced by a yellowish 
solution containing particles of inconsistent sizes). Contrariwise, 
decreasing the pH from 7.3 to 4.2 induced protonation of most of 
the surface carboxylate groups, leading to a zeta-potential value 
close to zero. Accordingly, the CPPs were highly prone to 
aggregate, which ultimately led to their precipitation. Interestingly, 
this aggregation and precipitation is reversible: bringing the pH 
back up enabled recovery of the stable colloidal suspension. 
Finally, when the pH was decreased to below 3.0 the CPPs 
rapidly decomposed. 
   Combined TGA/DSC and SEM experiments also evidence a 
considerable enhancement of the thermal and chemical stability 
most likely due to the formation of several hydrogen bonds within 
the core of the nanoparticle. CPP0-Co and CPP0-Fe 
nanoparticles begin to melt over 105 ºC and decompose over 220 
ºC, well over those found for other CPP families. For comparison 
purposes, model CPP1-Co nanoparticles obtained by 
replacement of dhc ligands by 3,4-di(tert-butyl) catechol groups 
were also studied. As expected, introduction of bulky tert-butyl 
groups without having the possibility to induced hydrogen bonds 
induces a decrease in the melting point down to ca. 60 ºC (see 
Supporting Information S2). Such difference in thermal stability 
can be translated to chemical robustness. Whereas CPP0 
nanoparticles are stable in water or PBS solution for several 
weeks, those of CPP1 remain only for a few days.   
Functionalization of CPP0 with the 6-aminofluorescein 
(ANF) fluorescent dye.  First attempts to couple the surface 
carboxyl groups of CPP0-Fe and CPP0-Co were done with a 6-
aminofluorescein dye in a water/ethanol solution at room 
temperature. After 24 h, stable ANF/CPP0-Fe and ANF/CPP0-Co 
nanoparticles were isolated without any morphological change 
concerning initial CPP0-Co (figure 3a). Successful coupling was 
indicated by the FTIR spectra; FT-IR spectrum lacked the 
characteristic NH2 stretching/bending bands (at 3500-3350 and 
1700-1500 cm-1) of the amine group from ANF and exhibited a 
less intense carboxylic acid C-OH stretching band (at 1300 cm-1) 
due to the carboxyl-amino surface coupling. The signal 
corresponding to the formation of the amide group is barely 
distinguishable, however, characteristic signals from 6-
aminofluorescein are observed. (see Supporting Information S3). 
Fluorescence measurements on ANF/CPP0-Fe and ANF/CPP0-
Co revealed that the nanoparticles display a strong green 
luminescence (emission peak centered at ca. 520 nm) upon 
excitation at 490 nm, both in solution and in solid state (Figure 
3b). Such excitation is characteristic of the ANF group, though 
coordinative bonding induces its maximum absorbance to shift 
upon partial hybridization with the metal ion (see Supporting 
Information S3). In contrast, under identical conditions, CPP0-Fe 
and CPP0-Co did not emit any fluorescence. The concentration 
of ANF on the CPPs surface was calculated by absorbance 
measurements (see Experimental Section) taking as reference 
the absorbance spectra of the corresponding non-functionalized 
nanoparticles. This calculation was not conclusive in the case of  
ANF/CPP0-Fe, however for ANF/CPP0-Co a concentration of 
1.58•10-9 mol ANF per mg of nanoparticles was calculated. 
 
Figure 3. a) SEM image of ANF/CPP0-Fe nanoparticles (inset: image of 
fluorescence microscopy); b) Normalized absorption (red) and emission (pink) 
spectra for the 6-aminofluorescein attached to the ANF/CPP0-Fe surface; c) 
Confocal laser scanning microscopy images of the internalized fluorescent 
nanoparticles (ANF/CPP0-Fe). 
 
 
Cellular uptake of NPs. After functionalization with the 
fluorescent dye, we then monitored the uptake of the 
fluorescently labeled ANF/CPP0 nanoparticles in MCF-7 cells 
using confocal laser scanning microscopy (CLSM). After 24 h of 
incubation, orthogonal views of CLSM images (Figure 3c, X Z) 
clearly exhibited the localization of these nanoparticles inside the 
cells. In contrast, no fluorescence was detected in untreated 
(control) cells. The cellular uptake of these nanoparticles was 
also investigated quantitatively. MCF-7 cells were incubated with 
ANF/CPP0-Co (100 µg/mL) or ANF/CPP0-Fe (100 µg/mL) for 24 
h, and then lysed in PBS-1% SDS. The fluorescently labeled 
CPPs inside of the cells were quantiﬁed by analyzing the cell 
lysate in a spectroﬂuorometer reader (extinction wavelength: 490 
nm; emission wavelength: 520 nm). The relative cellular 
internalization of ANF/CPP0-Co was 27%, and of fluorescently 
labeled ANF/CPP0-Fe, 39%. Transport mechanism of CPPs 
through the cell membrane is not known yet; though most likely it 
takes place through a endocytosis pathway, consistent with 
reports on anionic carboxylated and hydroxyl terminated PAMAM 
dendrimers.[17] This should be the case of our negatively charged 
particles at physiological pH (7.4).   
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Figure 4. SEM images of PEG/CPP0-Fe (a) and (b) PEG/CPP0-Co 
nanoparticles; c) Zeta-potential measurements of the PEG-functionalized 
nanoparticles (PEG/CPP0-Co and PEG/CPP0-Fe) and the corresponding non-
functionalized nanoparticles (CPP0-Co and CPP0-Fe). The decrease in free 
surface carboxylic groups after coupling with amino-PEG makes the zeta-
potential less negative, and the value correlates to the concentration of PEG 
chains on the surface; d) Stability of colloidal dispersions of CPP0-Fe and 
PEG/CPP0-Fe at different concentrations in PBS after 1 week: 1mg/ml (left) and 
5mg/ml(right). PEG is shown to improve the colloidal stability in PBS. 
 
Functionalization of CPP0 with polyethylene glycol (PEG). 
We also coupled the surface carboxyl groups of CPPs to amino-
functionalized NH2-PEG chains (O-(2-aminoethyl)polyethylene 
glycol 3,000) in a phosphate buffer solution (pH 7.4). The reaction 
afforded a colloidal suspension, which was centrifuged, and then 
washed several times with an ethanol/diethyl ether solution. The 
resulting PEG/CPP0-Fe and PEG/CPP0-Co solid was dried 
under vacuum. Successful coupling was indicated by the FTIR 
spectra of (see Supporting Information S4). As observed by SEM 
(Figure 4a-b), the new PEG/CPP0-Fe and PEG/CPP0-Co 
nanoparticles are 8 to 10% larger than the corresponding 
precursors CPP0-Fe and CPP0-Co and exhibit a 15% larger 
hydrodynamic radius based on DLS measurements, which we 
attributed to the presence of the PEG groups. Moreover, the 
surface charge can be also tuned by simply adjusting the pH of 
the buffer. For PEG/CPP0-Fe, increasing the pH to 9.0 led to a 
decrease in zeta-potential (from -11.4 mV to -22.3 mV) and 
consequently, to less particle aggregation in water (Figure 4c) —a 
feature which has previously been exploited for CPP0-Fe and 
CPP0-Co. More interesting is the comparison of colloidal 
dispersions of PEG/CPP0 and non-functionalized CPP0 
nanoparticles at different concentrations in a PBS phosphate 
buffer (1mg/mL and 5mg/mL). After 1 week the solutions 
containing CPP0-Fe nanoparticles had undergone notable 
sedimentation, whereas the PEG/CPP0-Fe dispersions remained 
much more stable, owing to the PEG groups (figure 4d). Finally, 
the surface concentration of PEG groups was determined by 1H-
NMR measurements (see Experimental Section). For this the 
integral ratios of PEG methylene protons obtained upon 
dissolution of the PEG/CPP0-Fe nanoparticles is compared with a 
calibration curve of blank PEG methylene protons measured at 
different concentrations resulting in a value of 8.42·10-3 mg 
(2.80•10-9 mol) of PEG per mg of nanoparticles, and a surface 
concentration of PEG chains around ∼13 pmol/cm2 (35% of the 
theoretical surface carboxyl groups; see Experimental Section). If 
compare the calculated PEG concentration with the 
corresponding ANF concentration in the surface of analogous 
CPPs we observed as increasing of 1.7 times the amount of PEG 
related to ANF. This difference can be due to different factors 
such as coupling reactivity, steric hindrance or others. Further 
studies will be necessary to elucidate the main factors that govern 
it.  
Cytotoxicity measurements. In order to investigate the 
cytotoxicity of the different nanoparticles on the MCF-7 breast 
cancer cells XTT assay was used. MCF-7 cells were treated 
during 24h with increasing doses of Fe and Co nanoparticles and 
the results indicate that MCF-7 cells retained more than 75% 
viability, in comparison with untreated cells, even at high 
nanoparticle concentrations (see Supporting Information S5). It 
could be suggested that the chemical composition of the 
nanoparticles and the low percentage of metal ions (less than 
10% in mass) did not contribute to toxicity. Thus, nanoparticles 
showed no cytotoxicity and thus great potential to be drug carriers. 
Encapsulation and drug delivery. To evaluate de 
effectiveness of these nanoplatforms as nanocarriers and their 
therapeutic potential as drug delivey systems for cancer 
treatment, CPP0-Fe nanoparticles were used to encapsulate 
campothecin (CPT). By addition of an aqueous solution of 
Fe(CH3COO)2 to an ethanolic solution containing the mixture 
bix/dhc and the drug ([CPT] = 3.0 x 10-3 M) under stirring at room 
temperature, the resulting nanoparticles (CPT@CPP0-Fe) were 
obtained. Afterwards the nanoparticles were purified by 
centrifugation and washed several times with ethanol. This 
process was repeated until no fluorescence signal from non-
encapsulated CPT was detected in the supernatant solution by 
fluorimetric measurements. Representative SEM and TEM 
images reveal the formation of the nanoparticles with a mean size 
of 112±19 nm and the entrapment of CPT was confirmed by both 
absorption and fluorescence measurements (Figure 5); 
efficiencies up to 18% were obtained with respect to the initial 
drug concentration by comparison with non-loaded blank 
nanoparticles.  
   Under these conditions, the half maximal inhibitory 
concentration (IC50) for CPT@CPP0-Fe was 2.79 ng and 1.16 ng 
CPT/ml, at 24h and 72h, respectively. The cytotoxicity effect of 
the free CPT in a MCF7 cellular culture at 24 h and 72 h under 
the same experimental conditions was also studied for 
comparison purposes. The half maximal inhibitory concentration 
(IC50) was 18.52 and 7.37 ng/ml at 24h and 72h, respectively. 
This represents an astonishing 6.5-fold drug efficacy increase 
upon encapsulation (Figure 5d). These excellent results have 
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been attributed to higher intracellular levels of CPT arising from 
an increased cellular uptake of the drug upon encapsulation.  
Figure 5. a) SEM image of CPT@CPP0-Fe nanoparticles; b)  Fluorescence 
optical microscope images of CPT@CPP0-Fe spheres (collected at exc = 355 
nm); c) Normalized absorption and emission spectra for CPT 
(absorption:blue/emission:green) and CPT@CPP0-Fe 
(absorption:black/emission:red); d) Cytotoxic effect of CPT@CPP0-Fe 
nanoparticles and comparison with free CPT at 24h (left) and 72h (right). Solid 
dots correspond to free drug and empty dots correspond to encapsulated CPT. 
 
Extrapolation to other compositions. Finally, to 
demonstrate that our new synthetic framework can be 
extrapolated to other reactive groups opening the possibility to 
systematically tune CPPs performance for drug delivery, we 
fabricated CPP platforms with ligands bearing a reactive 
aldehyde group. Following the methodology previously described 
but replacing the 3,4-dihydroxycinnamic acid (dhc) by the 3,4-
dihydroxybenzaldehyde (dhba) ligand, amorphous spherical 
nanoparticles with an average diameter of 100±12 nm (CPP2-Fe) 
were obtained as confirmed by combined SEM, DLS experiments 
and X-ray Powder Diffraction experiments. Fourier-transform 
infrared (FT-IR) spectra evidenced the coordination of the bix and 
catechol ligands to the metal and the permanence of the 
aldehyde group. Energy-Dispersive X-ray Spectroscopy 
confirmed the presence of the metal (Fe) and of carbon, oxygen 
and nitrogen. Afterwards we coupled the surface aldehyde groups 
of CPP2-Fe to a 1-Pyrenebutyric hydrazide (PBH) dye in a 
ethanolic solution, in presence of acetic acid and heating at 80ºC. 
After 6 h, stable PBH/CPP2-Fe nanoparticles were isolated 
without any morphological change concerning initial CPP2. 
Successful coupling was indicated by the FTIR spectra (see 
Supporting Information S6). 
Fluorescence measurements on PBH/CPP2-Fe revealed that 
the nanoparticles display a strong luminescence (emission peak 
centered at ca. 410 nm) upon excitation at 347 nm, both in 
solution and in solid state, confirming the validity of our approach. 
Conclusion 
We fabricated robust nanoparticles by incorporation of carboxyl 
groups. The resulting nanoscale CPP exhibit three main 
advantages: I) they offer a highly robust platform reinforced by 
several supramolecular hydrogen bonds within the polymeric 
network, while retaining the morphological characteristics and 
encapsulation capacities, II) surface carboxyl groups allow for the 
systematic control over the colloidal dispersion of CPPs and III) 
the surface carboxylates can be transformed into myriad 
functionalities through well-known peptide coupling reactions, 
which is difficult to achieve by direct formation. This has been 
demonstrated via labeling with new bioactive functional groups 
(fluorescent dyes or PEG).  
We have also explored their use as drug delivery carriers. 
CPT@CPP0-Fe nanoparticles have shown a 6.5-fold increase 
efficacy with respect to the free CPT, affording formulations with 
low clinically relevant IC50s. Moreover, the relatively high load 
capacity of drugs such as CPT, their low cytotoxicity, the 
possibility to image the cell internalization by functionalization 
with fluorescent groups and the control of colloidal stability in 
aqueous dispersions provide very promising and non-developed 
nanoplatforms with applications on drug delivery. 
Experimental Section 
Experimental Solvents and starting materials were purchased from Sigma-
Aldrich and used as received, without further purification, unless otherwise 
stated. 1,4-Bis(imidazol-1-ylmethyl)benzene (bix) 
[18]
 and CPP1-Co 
nanoparticles 
[19]
 were synthesized according to a previously reported methods. 
   Synthesis of CPP0-Co and CPP0-Fe. 1,4-Bis(imidazol-1-ylmethyl)benzene 
(59 mg, 0.25 mmol) and 3,4-dihydroxycinnamic acid (dhc, 90 mg, 0.5 mmol) 
were dissolved in 15 mL of ethanol. Under vigorous stirring (800 rpm) the 
solution was treated with an aqueous solution of either Co(CH3COO)2•4H2O 
(62.3 mg, 0.25 mmol in 2 mL H2O; for CPP0-Co) or Fe(CH3COO)2 (43.5 mg, 
0.25 mmol in 2 mL H2O; for CPP0-Fe), which turned it either brownish-green or 
dark blue, respectively, and led to rapid form ation of a precipitate. After the 
solution was stirred at room temperature for 30 minutes, the precipitate was 
collected by centrifugation, and then washed with ethanol several times. The 
solvent was removed and the solid was dried under vacuum. SEM and TEM 
images of the resulting spherical nanoparticles showed a size distribution of 
110±17 nm and 94±11 nm for CPP0-Co and CPP0-Fe respectively. C,H,N 
analysis (%) calcd for C32H28O8CoN4 : C 58.63, H 4.31, N 8.55; found: C 59.34, 
H 4.79, N 8.18. C,H,N analysis (%) calcd for C32H28O8FeN4: C 58.91, H 4.33, N 
8.59; found: C 59.48, H 4.92, N 8.40. FT-IR (ATR) CPP0-Co: ν =3412.5 (s), 
3092.4 (s), 1615.3 (s), 1585.2 (s), 1486.2 (m), 1396.4 (m), 1088.2 (m), 809.9 
(m), 727.7 (m), 658.21 (m) cm-1. FT-IR (ATR) CPP0-Fe: ν = 3422.1 (s), 3101.3 
(s), 1609.7 (s), 1478.6 (m), 1395.3 (m), 1095.4 (m), 798.9 (m), 722.5 (m), 657.3 
(m) cm-1. 
   Synthesis of CPP2-Fe. 1,4-Bis(imidazol-1-ylmethyl)benzene (59 mg, 0.25 
mmol) and 3,4-dihydroxybenzaldehyde (69 mg, 0.5 mmol) were firstly dissolved 
in 15 mL of ethanol. Under vigorous stirring (800 rpm), the solution was treated 
with an aqueous solution of Fe(CH3COO)2 (43.5 mg, 0.25 mmol in 2 mL H2O), 
which turned it light brown and led to rapid formation of a precipitate. After the 
solution was stirred at room temperature for 30 minutes, the precipitate was 
collected by centrifugation, and then washed with ethanol several times. The 
solvent was removed and the solid was dried under vacuum. SEM and TEM 
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images of the resulting spherical nanoparticles showed a size distribution of 
100±12 nm. C,H,N analysis (%) calcd for C28H24O6FeN4 : C 59.17, H 4.26, N 
9.86; found: C 59.49, H 4.35, N 10.01; FT-IR (ATR): ν =2361.2 (m), 2335.3 (m), 
1651.7 (m), 1570.6 (m), 1483.2(s), 1434.4 (m), 1282.5 (s), 1102.5 (m), 948.4 
(w), 821.4 (m), 750.3 (m), 640.1 (m) cm-1. 
   Synthesis of CPT@CPP0-Fe nanoparticles. These drug loaded spheres 
were obtained by addition of an aqueous solution (5 ml) of Fe(CH3COO)2 (109 
mg, 0.625 mmol) to an ethanolic solution (25 ml) containing a mixture of bix 
(147.5 mg, 0.625 mmol), dhc (225 mg, 1.25 mmol) and the drug CPT (3.0 x 10-
3 M) under vigorous stirring at room temperature. The resulting encapsulated 
metal-organic polymer nanoparticles were purified by centrifugation and washed 
at least three times with ethanol to eliminate impurities and rest of the drug 
adsorbed on the nanoparticles surface. The encapsulated systems were dried 
and storage under inert atmosphere in the freeze. These nanoparticles are 
easily redispersable in different organic solvents, water or phosphate buffer.  
   Functionalization of CPP0-Co/Fe CPPs with 6-aminofluorescein (ANF): 
To a stirring dispersion of 30 mg of nanoparticles in 15 mL of H2O/EtOH (4:1) 
were added 5 mg (0.014 mmol) of 6-aminofluorescein. After 10 minutes, EDC 
(10 mg, 0.05 mmol) and NHS (5.75 mg, 0.06 mmol) were added, and the 
mixture was stirred at room temperature for 6 hours. The resulting particles 
were purified by centrifugation, and then washed with ethanol several times to 
remove any excess starting material (the total absence of any remaining, non-
attached dye in the supernatant solution was confirmed by the absence of any 
fluorescence signal). The precipitate was dried under vacuum overnight. 
   Functionalization of CPP2-Co/Fe CPPs with 1-Pyrenebutyric hydrazide 
(PBH): To a stirring dispersion of 8 mg of nanoparticles in 6 mL of ethanol were 
added 3 mg (0.017 mmol) of 1-Pyrenebutyric hydrazide and one drop of acetic 
acid. The mixture was stirred at 80ºC for 8 hours. The resulting particles were 
purified by centrifugation, and then washed with water and ethanol several 
times to remove any excess of starting material (the total absence of any 
remaining, non-attached dye in the supernatant solution was confirmed by the 
absence of any fluorescence signal). The precipitate was dried under vacuum 
overnight.  
   Functionalization of CPP0-Co/Fe CPPs with O-(2-
aminoethyl)polyethylene glycol 3.000 (NH2-PEG). Carboxyl-functionalized 
CCPs (30mg) were dispersed in 10 mL of phosphate buffer solution (PBS, 50 
mM, pH 7.4). Subsequently, to activate the carboxylic acid groups, EDC (20 mg, 
0.10 mmol) and NHS (11.5 mg, 0.13 mmol) were added at room temperature 
and the solution was kept for 2 h under continuous stirring. Afterwards, 100 mg 
of PEG prepared in 5 mL of PBS were added and the solution was stirring for 
24 h at room temperature. The resulting nanoparticles were collected by 
centrifugation, washed with water and ethanol, and dried under vacuum.  
Characterization: Optical microscopy images were obtained with an Axio 
Observer Z-1 (Zeiss) inverted optical microscope, equipped with an XY 
motorized sample holder. The light source is a high-pressure Hg steam lamp of 
short arc (HBO 103/2 of 100W). The microscope is equipped with different 
objectives (5x, 10x, 20x, 50x, 100x) as well as filters for fluorescence 
measurements (DAPI: exc. BP 365/12, emis. LP 397; Alexa Fluor 488: exc. BP 
450, emis. LP 515; and Alexa Fluor 546: exc. BP 540/12, emis. LP 590). 
Fluorescence was detected with an AxioCam HRc camera with a Sony CCD 
sensor (resolution: 1388 x 1040 pixels = 1.4 Mpxl). SEM measurements were 
performed with a HITACHI S-570 operating at 15 kV. The samples were 
prepared by drop casting of the corresponding dispersion on aluminum tape 
followed by evaporation of the solvent under room conditions. Before analysis 
the samples were metalized with a thin layer of gold, using a sputter coater 
(Emitech K550). Transmission electron microscopy (TEM) images were 
acquired with a Jeol JEM-1400 microscope operating at 120 kV. The samples 
were prepared by casting a drop of the corresponding sample dispersion on a 
holey carbon copper grid, and then evaporating off the solvent under room 
temperature. Size distribution and surface charge of the nanoparticles were 
measured by DLS, using the Zetasizer Nano 3600 instrument (Malvern 
Instruments, UK), whose size range limit is 0.6 nm to 6 µm (5 nm to 10 µm for 
zeta-potential). Note: the diameter measured by DLS is the hydrodynamic 
diameter. The samples comprised aqueous dispersions of the nanoparticles in 
distilled water or in buffer. All samples were diluted to obtain an adequate 
nanoparticle concentration. The data reported are mean values for each sample, 
which were measured in quadruplicate. To study the influence of pH on zeta-
potential, the nanoparticles were dispersed in different PBS buffers (pH: 4.2, 7.3, 
9.0 or 12.0). The IR spectra have been recorded using a Tensor 27 (Bruker) 
spectrophotometer equipped with a single-reflection diamond window ATR 
accessory (MKII Golden Gate, Specac). Powder XRD spectra were recorded at 
room temperature on a high-resolution texture diffractometer (PANalytical 
X’Pert PRO MRD) equipped with a Co-Kα radiation source ( = 1.7903Å) and 
operating in reflection mode. The solid samples were placed in an amorphous 
silicon oxide flat plate and measured directly. 
   Determination of ANF concentration on CPPo nanoparticles. The 
concentration of ANF on the surface was calculated using a solution containing 
2 mg of ANF/CPP0 nanoparticles in 3ml of PBS by applying the Beer's Law (c = 
A / ε l); specifically molar extinction coefficient for 6-aminofluorescein εANF = 
83,000. The absorbance signal of the attached ANF was obtained by 
deconvolution the spectra of the functionalized nanoparticles taking as 
reference the absorbance spectra of the corresponding non-functionalized 
nanoparticles. This calculation was easy for ANF/CPP0-Co nanoparticles, 
however the high dispersion of the particles and broad signal of ANF in 
ANF/CPP0-Fe make difficult to obtain a good result (see Supporting Information 
S3). Once the ANF concentration in the dispersion is calculated, the amount of 
fluorescent dye per mg of nanoparticles can be easily calculated. For 
ANF/CPP0-Co : [ANF]calc = 1.06•10
-6
 M; that match with 1.58•10
-9
 mol ANF 
per mg of nanoparticles. 
   Determination of attached PEG groups by 
1
H-NMR. In a sample 
experiment, 20 mg of dry PEG/CPP0-Fe nanoparticles was re-dispersed in 
deuterated methanol. Two drops of deuterated hydrochloric acid were added to 
the solution to afford the complete dissolution and demetalation of the 
coordination polymer. 
1
H-NMR spectra (250 MHz) were recorded on a Bruker 
Avance DRX-250 spectrometer with chemical shifts and integration relative to 
an external reference. The external reference consisted of 10 µL acetone 
dissolved into 0.5 mL of deuterated methanol in a WILMAD coaxial insert tube 
immersed in the 5 mm NMR sample tube (acetone chemical shift: 2.15 ppm). 
For the calibration curve, NH2-PEG (MW 3000) with different known weights 
was dissolved in deuterated methanol, and the samples were characterized by 
NMR. The calibration curve was obtained by plotting the integral ratios of the 
PEG methylene protons (chemical shift: 3.25-3.60 ppm) against the external 
reference signal (see Supporting Information S7). By measuring the integral 
ratios of PEG methylene protons obtained from the dissolution of the 
coordination polymer respect to the same external reference, the average PEG 
concentration was obtained by comparison of the results with the calibration 
curve. The calculations afford an amount of 9.42·10
-3
 mg of PEG per mg of 
nanoparticles. The calculated surface area of the particles was then used to 
determine the surface concentration of PEG. By modeling the nanoparticles as 
perfect spheres of 100 nm size containing one –COOH group each ∼13Ǻ2 that 
correspond to the metal-metal separations in typical Co-bix complexes 
(between 12-14Ǻ), as extracted from different structural characterizations found 
in literature.
[20]
 Thus it is possible to give an estimate of the expected maximum 
coverage of the surface by the PEG chains. So, this theoretical approximation 
affords a maximum concentration of carboxyl groups on the nanoparticles 
surface around ∼38 pmol/cm2. With the known surface area of the particles 
used, the surface concentration of PEG can be determined accordingly.
[21]
 The 
calculated surface concentration of PEG obtained was ∼13 pmol/cm2 This 
translates to a functionalization level of 34% of the initial surface carboxyl 
groups, which is consistent with the estimated value (ca. 40%) obtained from 
zeta-potential studies by comparison of PEG functionalized and 
nonfunctionalized nanoparticles (see Supporting Information S7). 
Cytotoxicity assay. Human breast-cancer cells (MCF-7) were obtained from 
American Type Culture Collection (ATCC, Manassas, VA, USA). The cells were 
routinely cultured with DMEM F12 (Invitrogen) containing 10% heat-inactivated 
fetal bovine serum (FBS), at 37 ºC in a humidified (5%) CO2 atmosphere. The 
cytotoxicity of each type of nanoparticle was evaluated by the XTT (sodium 2,3,-
bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)-carbonyl]-2H-tetrazolium 
inner salt) assay. MCF-7 cells were plated at a density of 5 x 10
3
 cells/well in 
100 µL of culture medium in 96-well plates, and grown overnight. After 24 hours 
incubation with different concentrations (0, 10, 25, 50, 100, or 200 µg/mL) of 
each nanoparticle, 20 uL of XTT was added. After 3 hours incubation, the 
absorbance (at 490 nm) of each well was measured by a microplate reader 
(Victor3). The relative cell viability (%) for each sample related to the control 
well was calculated. Each sample was tested in quadruplicate. 
   Cellular uptake of NPs. MCF-7 cells were seeded in a 35 mm glass-bottom 
culture dish (MatTek Corporation, Ashland, MA) at a density of 4 x 10
5
 cells/well 
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and incubated for 24 hours. The cells were treated with one type of nanoparticle 
(either CPP0-Co, CPP0-Fe, PEG/CPP0-Fe or ANF/CPP0-Fe at 100 μg/mL), 
and then incubated for 24 hours at 37 °C. Prior to imaging, the cell membranes 
and nuclei were stained with Cell Mask™ Deep Red and Hoechst (Invitrogen), 
respectively, for 10 minutes. Fluorescence imaging was performed on a Leica 
TCS SP5 confocal fluorescence microscope. 
   The intracellular accumulation of ANF/CPP0-Fe was also quantified by 
fluorescence. Before the cell uptake experiments, MCF-7 cells were plated into 
six-well plates at a density of 4 x 10
5 
cells/well and incubated overnight. The 
medium from each well was replaced with 1 mL of medium containing 
ANF/CPP0-Fe nanoparticles. After 24 hours of nanoparticle exposure, the 
medium was removed, and the attached cells were washed and trypsinized, 
and the cell pellets were lysed with PBS 1% SDS. The lysates were analyzed in 
a Jasco FP-8200 spectrofluorometer (excitation: 490 nm; emission: 520 nm). 
Cellular uptake (%) was calculated from the ratio of fluorescein concentration 
after treatment to that before treatment. 
   Anticancer activity of CPT@CPP0-Fe nanoparticles. The anticancer 
activity of CPT@CPP0-Fe nanoparticles was measured by the XTT assay using 
free CPT as a control . After incubating MCF-7 breast cancer cells with free 
CPT or CPT@CPP0-Fe nanoparticles (1, 2.5, 5, 7.5, 10, 25, 50 and 100 ng/mL) 
for 24 or 72h, 20 uL of XTT was added. After 3 h incubation, the cell viability 
was quantified using a microplate reader (Victor3). For IC50 calculations, 
survival data were evaluated by variable slope curve-fitting using Prism 4.0 
software (GraphPad, San Diego, CA). 
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